Ricky Goldwasser

Cigna Corp (NYSE: CI) is poised to benefit from the launch of bioequivalent Humira in July 2023, according to Morgan Stanley. The Cigna Analyst: Ricky Goldwasser upgraded the rating for Cigna from Equal-Weight to Overweight, while raising the price target from $283 to $296. The Cigna Thesis: The...

Diplomat Pharmacy Inc (NYSE: DPLO) cautioned investors on Tuesday that it has "substantial doubts" related to its ability to continue functioning as a business. Some analysts aren't ready to throw in the towel just yet — and see upside after Tuesday's all-time lows...

Shares of Livongo Health Inc (NASDAQ: LVGO) have lost nearly 20% since its late July IPO, and investors should take advantage of the discount valuation, according to Morgan Stanley. The Analyst Ricky Goldwasser upgraded Livongo Health from Equal-weight to Overweight with an unchanged $42 price...

Livongo Health Inc (NASDAQ: LVGO) shares have bumped up more than 30% since the company went public at the end of July, raising interest in the digital health platform company. But analysts’ opinions were mixed as two firms started coverage on Monday. The Analysts KeyBanc Capital Market's...

CVS Health Corp (NYSE: CVS) laid out its ideas for growing earnings growth from the low single digits expected next year, giving analysts a look at a plan that includes a turnaround in its retail long-term care business, growth at its acquired health insurer Aetna and faster-than-expected ramp up...

Walgreens Boots Alliance Inc (NASDAQ: WBA) on Tuesday reported fiscal second-quarter results that fell short of expectations in what management described as the "most difficult" quarter since late 2014. Here is a summary of how some of the Street's top analysts reacted to the print....

Diplomat Pharmacy Inc (NYSE: DPLO) on Friday reported its previously delayed fourth-quarter earnings miss and concerning guidance, which sent the stock tumbling nearly 14 percent. The Analysts Mizuho Securities' Ann Hynes maintains a Neutral rating on Diplomat Pharmacy with a price target...

Barely a month-and-a-half after upgrading Quest Diagnostics Inc (NYSE: DGX) to Equal-weight, Morgan Stanley turned incrementally positive on the shares. The Analyst Analyst Ricky Goldwasser upgraded shares of Quest Diagnostics from Equal-weight to Overweight and increased the price target...

Inovalon Holdings Inc (NASDAQ: INOV), a technology company providing cloud-based platforms to the health care industry, is beset by client losses, ACA headwinds and pricing concerns, an analyst at Morgan Stanley said. The Analyst Morgan Stanley's Ricky Goldwasser downgraded Inovalon from...

CVS Health Corp (NYSE: CVS)'s proposed acquisition of Aetna Inc (NYSE: AET) is reason enough for at least one Wall Street analyst to turn bullish. The Analyst Morgan Stanley's Ricky Goldwasser upgraded CVS' stock from Equal-weight to Overweight with a price target boosted from $...

Amazon.com, Inc. (NASDAQ: AMZN) poses an existential threat to a host of retailers, and even to companies outside the retail arena. Drug distributor Cardinal Health Inc (NYSE: CAH) could be one among them, according to Morgan Stanley.  The Analyst Morgan Stanley analyst Ricky...

The bullish case for owning Walgreens Boots Alliance Inc (NASDAQ: WBA) has come to an end, says analysts at Morgan Stanley. The firm's Ricky Goldwasser downgrades Walgreens Boots' stock rating from Overweight to Equal-Weight with a price target lowered from $95 to $85. Walgreens is expected to...

Patheon NV (NYSE: PTHN) is positioned for above-market organic growth with an end-to-end service contract manufacturing (CMO) model, according to a note from Morgan Stanley that initiated coverage of the stock with an Overweight rating and price target of $31. "High operating leverage can drive ~...